Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 9, Pages 2704
Publisher
MDPI AG
Online
2018-09-11
DOI
10.3390/ijms19092704
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework
- (2018) Lan Xu et al. JOURNAL OF CLINICAL VIROLOGY
- Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice
- (2017) Nicolas Wentzensen et al. INTERNATIONAL JOURNAL OF CANCER
- Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel
- (2017) N. J. Polman et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Performance of a Cartridge-Based Assay for Detection of Clinically Significant Human Papillomavirus (HPV) Infection: Lessons from VALGENT (Validation of HPV Genotyping Tests)
- (2016) Kate Cuschieri et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework
- (2016) I. Heard et al. JOURNAL OF CLINICAL VIROLOGY
- VALGENT: A protocol for clinical validation of human papillomavirus assays
- (2016) Marc Arbyn et al. JOURNAL OF CLINICAL VIROLOGY
- Commercially available molecular tests for human papillomaviruses (HPV): 2015 update
- (2016) Mario Poljak et al. JOURNAL OF CLINICAL VIROLOGY
- Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
- (2015) M. Arbyn et al. CLINICAL MICROBIOLOGY AND INFECTION
- Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: Data from the ATHENA trial
- (2015) Joseph Monsonego et al. GYNECOLOGIC ONCOLOGY
- Clinical and Analytical Performance of the Onclarity HPV Assay Using the VALGENT Framework
- (2015) K. Cuschieri et al. JOURNAL OF CLINICAL MICROBIOLOGY
- International standardization and classification of human papillomavirus types
- (2015) Davit Bzhalava et al. VIROLOGY
- Clinical Evaluation of a GP5+/6+-Based Luminex Assay Having Full High-Risk Human Papillomavirus Genotyping Capability and an Internal Control
- (2014) D. T. Geraets et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Are 20 human papillomavirus types causing cervical cancer?
- (2014) Marc Arbyn et al. JOURNAL OF PATHOLOGY
- Viral Load of High-Risk Human Papillomaviruses as Reliable Clinical Predictor for the Presence of Cervical Lesions
- (2013) M. Schmitt et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Multiple Human Papillomavirus Infections with High Viral Loads Are Associated with Cervical Lesions but Do Not Differentiate Grades of Cervical Abnormalities
- (2013) M. Schmitt et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
- (2013) Guglielmo Ronco et al. LANCET
- Prevalence and viral load of 51 genital human papillomavirus types and three subtypes
- (2012) Markus Schmitt et al. INTERNATIONAL JOURNAL OF CANCER
- Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
- (2012) Marc Arbyn et al. VACCINE
- Comparison of Clinical and Analytical Performance of the Abbott RealTime High Risk HPV Test to the Performance of Hybrid Capture 2 in Population-Based Cervical Cancer Screening
- (2011) M. Poljak et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study
- (2011) Philip E Castle et al. LANCET ONCOLOGY
- Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial
- (2011) Dorien C Rijkaart et al. LANCET ONCOLOGY
- European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition--Summary Document
- (2010) M. Arbyn et al. ANNALS OF ONCOLOGY
- Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening
- (2009) P. Naucler et al. JNCI-Journal of the National Cancer Institute
- HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial
- (2009) Henry C Kitchener et al. LANCET ONCOLOGY
- A review of human carcinogens—Part B: biological agents
- (2009) Véronique Bouvard et al. LANCET ONCOLOGY
- HPV Screening for Cervical Cancer in Rural India
- (2009) Rengaswamy Sankaranarayanan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
- (2008) Chris J.L.M. Meijer et al. INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More